Skip to content

Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation.

Superior Laryngeal Nerve Block Versus Sedation with Intravenous Dexmedetomidine Infusion for Awake Fiberoptic Intubation of Hemimandibulectomy Patients with an Anticipated Difficult Airway: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06651905
Enrollment
80
Registered
2024-10-22
Start date
2024-01-01
Completion date
2024-09-01
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticipated Difficult Airway, Awake Fiberoptic Intubation, Dexmedetomidine, Hemimandibulectomy, Sedation, Superior Laryngeal Nerve Block

Brief summary

This study compares the efficacy and safety of dexmedetomidine infusion versus superior laryngeal nerve block during awake fiberoptic intubation in hemimandibulectomy patients.

Interventions

DRUGDexmedetomidine

The patients were given 0.5 mcg /kg dexmedetomidine over 10 min via syringe pump, followed by 0.2-0.7 mcg/kg/hour until the end of intubation according to hemodynamics.

The patients received an airway nerve block through bilateral superior laryngeal nerve block and trans-tracheal injection for recurrent laryngeal nerve.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age range ≥ 18 or ≤60. * Both sexes. * American Society of Anesthesiologists (ASA) II-III. * Body mass index:18.5 to 30 kg/m2. * Hemimandibulectomy patients with an anticipated difficult airway \[El-Ganzouri Risk Index (EGRI)\>3\].

Exclusion criteria

* Patient's refusal. * Known allergy to drugs used in the study. * Neurological disorders. * Advanced liver or kidney disease. * Patient with psychiatric disorders. * Patient who needs postoperative ICU. * Airway distortion and cervical spine movement.

Design outcomes

Primary

MeasureTime frameDescription
The intubation scoretime from introduction of scope of fibroptic device in the mouth of the patient to the insertion of the endotracheal tube between the vocal cords.Time range of 10 minutesThe intubation conditions score is assessed based on the following criteria: (i) Vocal movement: 1 = open, 2 = moving, 3 = closing, 4 = closed. (ii) Coughing: 1 = none, 2 = slight, 3 = moderate, 4 = severe. (iii) Limb movement: 1 = none, 2 = slight, 3 = moderate, 4 = severe. Where The Intubation conditions score is : Excellent = 1 when all qualities are excellent. Good = 2 when all qualities are either excellent or good. Poor = 3 when the presence of a single poor quality is noted.

Secondary

MeasureTime frameDescription
The degree of comforttime from introduction of scope of fibroptic device in the mouth of the patient to the insertion of the endotracheal tube between the vocal cords. Time range of 10 minutesThe comfort score was evaluated using a five-point fiberoptic intubation comfort scale: 1 = no reaction, 2 = slight grimace, 3 = heavy grimace, 4 = verbal objection, and 5 = defensive movement of head and hands.
Degree of airway obstructiontime from introduction of scope of fibroptic device in the mouth of the patient to the insertion of the endotracheal tube between the vocal cords Time range of 10 minutesThe degree of airway obstruction (1 - absent, 2 - requiring neck extension, 3 - requiring jaw thrust) was noted
Heart rateFrom one minute before intubation to 10 minutes after intubationHeart rate is recorded at 1-minute intervals until intubation is completed, followed by measurements every two minutes until 10 minutes after intubation.
Mean arterial pressureFrom one minute before intubation till10 minutes after intubationMean arterial blood pressure is recorded at 1-minute intervals until intubation is completed, followed by measurements every two minutes until 10 minutes after intubation.
Ramsay sedation scoreFrom time of injection of Drugs (Dexetodomidine , Lidocaine) to the patient to 10 minutes after intubationRamsay sedation score was recorded as follows: 1: Awake, agitated or restless or both; 2: Awake, cooperative, oriented, and tranquil; 3: Awake but responds to commands only; 4: Asleep, with a brisk response to a light glabellar tap or loud auditory stimulus.
Patient satisfaction scoreFrom the end of the operation to 24 hours postoperativeThe patient satisfaction score (1-excellent, 2-good, 3-reasonable, 4-poor) was documented.
Incidence of complicationsFrom the end of the operation to 24 hours postoperativeAdverse events such as bradycardia, hypotension, nausea, vomiting, pruritus, respiratory depression, O2 desaturation, or any other complications were recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026